Remove terms-of-use
article thumbnail

Episode 887: Long Term Outcomes of Haloperidol Use in the Agents Intervening against Delirium in the ICU Trial

Pharmacy Joe

In this episode, I’ll discuss a pre-planned analysis of long term outcomes of haloperidol use in the Agents Intervening against Delirium in the ICU Trial. Patients were split between treatment with haloperidol or placebo. The IV haloperidol group received 2.5 mg 3 times daily plus 2.5 However, the mortality rate at 90 days was 36.3%

article thumbnail

Episode 887: Long Term Outcomes of Haloperidol Use in the Agents Intervening against Delirium in the ICU Trial

Pharmacy Joe

In this episode, I’ll discuss a pre-planned analysis of long term outcomes of haloperidol use in the Agents Intervening against Delirium in the ICU Trial. Patients were split between treatment with haloperidol or placebo. The IV haloperidol group received 2.5 mg 3 times daily plus 2.5 However, the mortality rate at 90 days was 36.3%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: More than half the slots on a key vaccine advisory panel are vacant. Where’s HHS?

STAT

vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members. There is no chairperson.

Vaccines 360
article thumbnail

Opinion: STAT+: Use evidence to support early coverage of gene therapy after accelerated approval

STAT

With so little known about the long-term risks of gene therapy, we contend that the safest and best value to both patients and society will emerge within a framework of early evidence-development strategies following early coverage decisions. Bill Cassidy (R-La.) Now in their early days, gene therapies represent an evidence problem.

265
265
article thumbnail

STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier

STAT

WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word. as the enemy, we don’t ourselves use that term,” said Maisha Meds’ founder and CEO, Jessica Vernon. By definition, it’s a PBM.

308
308
article thumbnail

Positive safety data for long-term use of MS drug Kesimpta

pharmaphorum

Novartis announced the findings at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), revealing that mean immunoglobulin G (IgG) levels in patients treated with Kesimpta (ofatumumab) remained stable, and there was no apparent association between decreased IgG levels and the risk of serious infections.

article thumbnail

Nearly 1 in 10 teens globally have used ‘budget Ozempic’ laxatives and other risky weight loss products, per study

STAT

Nearly 1 in 10 adolescents around the globe have used non-prescription weight loss products like these already in their lifetime, according to new research published Wednesday in JAMA Network Open. Experts say the use of such products at a young age can pose both immediate and longer-term health risks. Read the rest…

361
361